Teva and Mylan are continuing to press their takeover bids in an increasingly hostile M&A chain, while Perrigo remains staunch in its defence. Ireland-based Perrigo has just rejected Mylan's third ...

Europe’s regulator has called for generic medicines from manufacturers including Novartis’ Sandoz unit, Teva and Mylan to be pulled from the market, after US inspectors found evidence that ...

JNJ sued Mylan, now part of Viatris and Teva over patent infringement concerns for proposed generic versions of the drug in ...

Teva Pharmaceuticals will sell a generic copy of Mylan’s EpiPen, which became the target of public outrage over its price. The F.D.A. says the shortage of the lifesaving device is ‘short-term ...

The drug distributor was once called Mylan, FOX 5 Atlanta reports ... 600 in some locations for those without insurance. In ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

After handing over $30 million in criminal penalties last summer, Glenmark Pharmaceuticals has agreed to settle with the U.S. government over claims it fixed the price on a popular cholesterol ...

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.

Teva's reasonable valuation, an improving pipeline and the prospect of growth in sales and profits are good enough reasons for those who own the stock to stay invested. TEL AVIV, Israel, Sept. 11 ...

BRUSSELS, Sept 10 (Reuters) - Teva (TEVA.TA), opens new tab, the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a rival product to its ...